| Medicare NCD | NCD 190.22 - Thyroid Testing | 2026-01-01 |
| Medicare NCD | NCD 190.23 - Lipids Testing | 2026-01-01 |
| Medicare NCD | NCD 190.24 - Digoxin Therapeutic Drug Assay | 2026-01-01 |
| Medicare NCD | NCD 190.25 - Alpha-fetoprotein | 2026-01-01 |
| Medicare NCD | NCD 190.26 - Carcinoembryonic Antigen | 2026-01-01 |
| Medicare NCD | NCD 190.27 - Human Chorionic Gonadotropin | 2026-01-01 |
| Medicare NCD | NCD 190.28 - Tumor Antigen by Immunoassay CA | 2026-01-01 |
| Medicare NCD | NCD 190.29 - Tumor Antigen by Immunoassay CA 15-3/CA 27.29 | 2026-01-01 |
| Medicare NCD | NCD 190.30 - Tumor Antigen by Immunoassay CA 19-9 | 2026-01-01 |
| Medicare NCD | NCD 190.31 - Prostate Specific Antigen | 2026-01-01 |